MA50229A - Composés complexes de fer à usage thérapeutique - Google Patents
Composés complexes de fer à usage thérapeutiqueInfo
- Publication number
- MA50229A MA50229A MA050229A MA50229A MA50229A MA 50229 A MA50229 A MA 50229A MA 050229 A MA050229 A MA 050229A MA 50229 A MA50229 A MA 50229A MA 50229 A MA50229 A MA 50229A
- Authority
- MA
- Morocco
- Prior art keywords
- therapeutic use
- iron complexes
- complexes
- iron
- therapeutic
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17190302 | 2017-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50229A true MA50229A (fr) | 2020-07-22 |
Family
ID=59923237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050229A MA50229A (fr) | 2017-09-11 | 2018-09-10 | Composés complexes de fer à usage thérapeutique |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11111261B2 (fr) |
| EP (1) | EP3681539A1 (fr) |
| JP (2) | JP7426927B2 (fr) |
| KR (1) | KR20200044030A (fr) |
| CN (1) | CN111050802A (fr) |
| AU (2) | AU2018328052C1 (fr) |
| BR (1) | BR112020004357A2 (fr) |
| MA (1) | MA50229A (fr) |
| MX (3) | MX2020002527A (fr) |
| SG (1) | SG11202001594TA (fr) |
| WO (1) | WO2019048674A1 (fr) |
| ZA (1) | ZA202001283B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020004357A2 (pt) * | 2017-09-11 | 2020-09-08 | Pharmacosmos Holding A/S | compostos de complexo de ferro para uso terapêutico |
| CA3125413A1 (fr) | 2019-01-10 | 2020-07-16 | Pharmacosmos Holding A/S | Traitement d'une carence en fer chez des sujets presentant un risque d'evenements cardiovasculaires indesirables et fer pour la prise en charge de la fibrillation auriculaire |
| SG11202109323UA (en) | 2019-02-28 | 2021-09-29 | Renibus Therapeutics Inc | Novel iron compositions and methods of making and using the same |
| EA202191858A1 (ru) | 2019-06-12 | 2021-11-12 | Фармакосмос Холдинг А/С | Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий |
| JP2024529536A (ja) | 2021-08-03 | 2024-08-06 | ファーマコスモス ホールディング エー／エス | コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物 |
| CN114376981B (zh) * | 2022-01-13 | 2023-10-20 | 上海医药集团青岛国风药业股份有限公司 | 一种多糖铁复合物胶囊的制备方法 |
| CN115177625A (zh) * | 2022-06-28 | 2022-10-14 | 金陵药业股份有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR607134A (fr) | 1924-12-03 | 1926-06-26 | Basf Ag | Procédé pour la production du fer carbonyle |
| FR654013A (fr) * | 1928-05-09 | 1929-03-30 | Procédé de réglage de la carburation dans les moteurs à explosions et dispositifen permettant la réalisation | |
| US2096855A (en) * | 1934-07-27 | 1937-10-26 | Innis Speiden & Co | Manufacture of ferric chloride |
| US3639588A (en) | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
| US3906077A (en) | 1974-02-15 | 1975-09-16 | Kerr Mc Gee Chem Corp | Purification of ferric chloride |
| US4056386A (en) | 1977-04-19 | 1977-11-01 | The United States Of America As Represented By The Secretary Of The Navy | Method for decomposing iron pentacarbonyl |
| WO1999043408A1 (fr) | 1998-02-25 | 1999-09-02 | Wadhawan Satish C | Extraction du chlorure ferrique avec un solvant |
| DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
| US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| US20060134227A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
| ITMO20050056A1 (it) * | 2005-03-15 | 2006-09-16 | Biofer Spa | Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi. |
| GB0702270D0 (en) * | 2007-02-06 | 2007-03-14 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
| EP2125847B1 (fr) | 2007-02-06 | 2015-06-17 | Medical Research Council | Matières poly oxo-hydroxy ion métallique modifiées par ligand, leurs utilisations et leurs procédés de préparation |
| NZ595597A (en) * | 2009-03-25 | 2013-05-31 | Pharmacosmos Holding As | A stable iron oligosaccharide compound |
| CN102065406B (zh) | 2009-11-12 | 2014-04-09 | 中兴通讯股份有限公司 | 一种本地呼叫本地交换的实现方法 |
| ES2743223T3 (es) | 2014-10-27 | 2020-02-18 | Pharmacosmos Holding As | Tratamiento o prevención de la anemia en mamíferos no humanos gestantes y crías |
| EP2913054A1 (fr) * | 2015-03-19 | 2015-09-02 | Pharmacosmos Holding A/s | Hydrate de carbone de fer complexe pour le traitement du syndrome des jambes sans repos (sjsr) |
| WO2016181195A1 (fr) * | 2015-05-08 | 2016-11-17 | Suven Life Sciences Limited | Procédé amélioré pour des complexes d'hydrate de carbone et de fer solubles dans l'eau |
| BR112017028025B1 (pt) | 2015-06-22 | 2023-04-18 | Pharmacosmos Holding A/S | Usos de um complexo de ferro-carboidrato para o tratamento ou prevenção de uma deficiência de ferro de um feto ou de um bebê |
| CN105095365A (zh) | 2015-06-26 | 2015-11-25 | 北京奇虎科技有限公司 | 一种信息流数据的处理方法和装置 |
| EP3459550B1 (fr) * | 2016-05-20 | 2021-07-07 | Obshestvo S Ogranichennoj Otvetstvennostju "Vikzdorove Zhivotnyh" | Composition pour injection d'un complexe de fer et de dextrane avec des vitamines pour la prévention des anémies |
| BR112020004357A2 (pt) * | 2017-09-11 | 2020-09-08 | Pharmacosmos Holding A/S | compostos de complexo de ferro para uso terapêutico |
-
2018
- 2018-09-10 BR BR112020004357-5A patent/BR112020004357A2/pt unknown
- 2018-09-10 MA MA050229A patent/MA50229A/fr unknown
- 2018-09-10 WO PCT/EP2018/074293 patent/WO2019048674A1/fr unknown
- 2018-09-10 JP JP2020513641A patent/JP7426927B2/ja active Active
- 2018-09-10 MX MX2020002527A patent/MX2020002527A/es unknown
- 2018-09-10 KR KR1020207007664A patent/KR20200044030A/ko not_active Application Discontinuation
- 2018-09-10 SG SG11202001594TA patent/SG11202001594TA/en unknown
- 2018-09-10 EP EP18762868.0A patent/EP3681539A1/fr active Pending
- 2018-09-10 AU AU2018328052A patent/AU2018328052C1/en active Active
- 2018-09-10 CN CN201880058623.0A patent/CN111050802A/zh active Pending
-
2019
- 2019-02-13 US US16/274,552 patent/US11111261B2/en active Active
-
2020
- 2020-02-28 ZA ZA2020/01283A patent/ZA202001283B/en unknown
- 2020-03-05 MX MX2023007810A patent/MX2023007810A/es unknown
- 2020-03-05 MX MX2023007809A patent/MX2023007809A/es unknown
-
2021
- 2021-08-18 US US17/405,438 patent/US20220041640A1/en not_active Abandoned
-
2023
- 2023-08-25 JP JP2023137244A patent/JP2023164477A/ja active Pending
-
2024
- 2024-01-24 US US18/421,494 patent/US20240279262A1/en active Pending
- 2024-05-29 AU AU2024203596A patent/AU2024203596A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220041640A1 (en) | 2022-02-10 |
| US20240279262A1 (en) | 2024-08-22 |
| JP2023164477A (ja) | 2023-11-10 |
| AU2018328052B2 (en) | 2024-02-29 |
| JP7426927B2 (ja) | 2024-02-02 |
| BR112020004357A2 (pt) | 2020-09-08 |
| RU2020113257A3 (fr) | 2022-04-25 |
| SG11202001594TA (en) | 2020-03-30 |
| ZA202001283B (en) | 2022-11-30 |
| AU2024203596A1 (en) | 2024-06-20 |
| WO2019048674A1 (fr) | 2019-03-14 |
| AU2018328052C1 (en) | 2024-08-08 |
| EP3681539A1 (fr) | 2020-07-22 |
| US11111261B2 (en) | 2021-09-07 |
| MX2020002527A (es) | 2020-10-12 |
| US20190177353A1 (en) | 2019-06-13 |
| MX2023007810A (es) | 2023-07-11 |
| RU2020113257A (ru) | 2021-10-13 |
| MX2023007809A (es) | 2023-07-11 |
| AU2018328052A1 (en) | 2020-03-26 |
| CN111050802A (zh) | 2020-04-21 |
| JP2020533300A (ja) | 2020-11-19 |
| KR20200044030A (ko) | 2020-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50229A (fr) | Composés complexes de fer à usage thérapeutique | |
| GB201820166D0 (en) | Therapeutic agents | |
| GB201709456D0 (en) | Therapeutic agents | |
| GB201820165D0 (en) | Therapeutic agents | |
| DK3784103T3 (da) | Gulvbehandlingsmaskine | |
| DK3870578T3 (da) | Terapeutiske forbindelser | |
| MA44020A (fr) | Composés antitumoraux | |
| GB201805816D0 (en) | Therapeutic agents | |
| GB201716942D0 (en) | Therapeutic compounds | |
| MA51221A (fr) | Composés de pyrazolopyridinone | |
| GB201700553D0 (en) | Therapeutic agents | |
| GB201600376D0 (en) | Novel therapeutic agents | |
| MA48946A (fr) | Composés | |
| UA41940S (uk) | Праска | |
| UA41934S (uk) | Праска | |
| UA41436S (uk) | Праска | |
| UA41939S (uk) | Праска | |
| UA40482S (uk) | Праска | |
| UA40485S (uk) | Праска | |
| UA40491S (uk) | Праска | |
| UA39227S (uk) | Праска | |
| UA38615S (uk) | Праска | |
| UA38826S (uk) | Праска | |
| UA38256S (uk) | Праска | |
| GB201820162D0 (en) | Therapeutic agents |